3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
22
Thoracic
4
Gynecologic
4
Genitourinary
3
Gastrointestinal
3
Dermatologic
3
Sarcoma
2
Plasma cell
1
Other hematologic neoplasm
1
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
39
Oropharyngeal Neoplasms
24
Mouth Neoplasms
21
Laryngeal Neoplasms
19
Head and Neck Neoplasms
19
Carcinoma
19
Thyroid Neoplasms
17
Hypopharyngeal Neoplasms
16
Thyroid Cancer, Papillary
10
Salivary Gland Neoplasms
10
Nasopharyngeal Carcinoma
10
Adenocarcinoma, Follicular
9
Lung Neoplasms
7
Carcinoma, Squamous Cell
7
Colorectal Neoplasms
6
Breast Neoplasms
6
Brain Neoplasms
6
Uterine Cervical Neoplasms
5
Neoplasm Metastasis
5
Melanoma
5
Carcinoma, Transitional Cell
5
Neoplasms
4
Esophageal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Carcinoma, Hepatocellular
4
Urinary Bladder Neoplasms
3
Stomach Neoplasms
3
Prostatic Neoplasms
3
Pancreatic Neoplasms
3
Neuroendocrine Tumors
3
Interventions
pembrolizumab
31
Nivolumab
11
Ipilimumab
6
spartalizumab
5
cemiplimab
5
atezolizumab
5
Gemcitabine
4
Docetaxel
4
durvalumab
3
budigalimab
3
avelumab
3
Oxaliplatin
3
Leucovorin
3
Irinotecan
3
Immune Checkpoint Inhibitors
3
Fluorouracil
3
Cyclophosphamide
3
Cetuximab
3
Carboplatin
3
130-nm albumin-bound paclitaxel
3
obinutuzumab
2
lenvatinib
2
fludarabine
2
epacadostat
2
X-Rays
2
Paclitaxel
2
Immunoglobulin G
2
Cisplatin
2
Capecitabine
2
Biopsy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Triple Negative Breast Neoplasms
×
Magnetic Resonance Spectroscopy
×
Head & Neck
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled